Peer-reviewed veterinary case report
Mousse with adelmidrol may reduce oily skin in cats with atopic
By Noli, Chiara et al.·Published in Veterinary dermatology·2025·Servizi Dermatologici Veterinari, Italy·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: An open-label pilot study on an adsorbent mousse containing adelmidrol in client-owned cats with feline atopic skin syndrome and associated seborrhoea.
- Species:
- cat
Plain-English summary
A group of seven cats with feline atopic skin syndrome (FASS) and skin flaking were treated with a special mousse containing tapioca starch and adelmidrol to see if it could help reduce their symptoms. Owners reported improvements in their cats' skin condition and itching after two weeks of treatment, with significant decreases in both skin flaking and itchiness. Most veterinarians involved were satisfied with the results, and some cats continued to show improvements even after four weeks. This treatment shows promise for helping cats with FASS-related skin issues.
People also search for: cat skin problems treatment · feline atopic dermatitis mousse · cat itching relief · seborrhoea in cats · how to help cat with skin allergies
Abstract
BACKGROUND: Besides pruritus and skin lesions, cats with feline atopic skin syndrome (FASS) may have seborrhoea. HYPOTHESIS/OBJECTIVES: The aim of this pilot study was to investigate whether an adsorbent mousse containing tapioca starch, adelmidrol and a nonpharmacological antimicrobial complex could decrease FASS-associated seborrhoea in cats. ANIMALS: Seven client-owned cats with FASS were included based on the presence of seborrhoea and pruritus (>4 cm on the validated feline pruritus Visual Analog Scale [VAScat]), regardless of the concomitant administration of antiallergic drugs, provided that they were used for ≥1 month before study entry and maintained unchanged. MATERIALS AND METHODS: Cats were evaluated weekly by owners and every other week by veterinary surgeons for 2 (optionally 4) weeks using a four-item skin seborrhoeic index (SSI). The VAScat and the scoring feline allergic dermatitis (SCORFAD) index also were used to assess pruritus and skin lesion severity, respectively. The Wilcoxon signed-rank test was used for pre- versus post-treatment comparisons. RESULTS: At the end of Week 2, the mean score value for SSI was significantly decreased (p = 0.016). At the same time point, the mean severity of pruritus and the mean SCORFAD index value had also decreased (p = 0.016). Moreover, 86% of the investigators were 'satisfied' or 'very satisfied' with the tested mousse. Four cats continued the study up to Week 4 and showed a further, albeit nonsignificant, decrease in all evaluated scores. CONCLUSIONS AND CLINICAL RELEVANCE: These preliminary findings have promising implications for clinical practice in cats with FASS-associated seborrhoea and are worth further investigation.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40314094/